11/5
11:19 am
bcrx
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $10.00 price target on the stock.
Low
Report
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $10.00 price target on the stock.
11/5
11:19 am
bcrx
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $10.00 price target on the stock.
Low
Report
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $10.00 price target on the stock.
11/5
11:13 am
bcrx
Rating for BCRX
Low
Report
Rating for BCRX
11/5
11:13 am
bcrx
Rating for BCRX
Low
Report
Rating for BCRX
11/5
10:41 am
bcrx
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $14.00 price target on the stock.
Low
Report
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $14.00 price target on the stock.
11/5
09:49 am
bcrx
Rating for BCRX
Low
Report
Rating for BCRX
11/5
09:49 am
bcrx
Rating for BCRX
Low
Report
Rating for BCRX
11/5
08:39 am
bcrx
Rating for BCRX
Medium
Report
Rating for BCRX
11/5
08:39 am
bcrx
Rating for BCRX
Medium
Report
Rating for BCRX